Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) alleging that the company made false and misleading statements regarding the inconsistent results of its reproxalap clinical trials. The lawsuit covers investors who purchased Aldeyra securities between November 3, 2023, and March 16, 2026. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of May 29, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin